PA8641501A1 - Derivados de cci-779 y metodo para su preparacion - Google Patents
Derivados de cci-779 y metodo para su preparacionInfo
- Publication number
- PA8641501A1 PA8641501A1 PA20058641501A PA8641501A PA8641501A1 PA 8641501 A1 PA8641501 A1 PA 8641501A1 PA 20058641501 A PA20058641501 A PA 20058641501A PA 8641501 A PA8641501 A PA 8641501A PA 8641501 A1 PA8641501 A1 PA 8641501A1
- Authority
- PA
- Panama
- Prior art keywords
- cci
- derivatives
- preparation
- metabolites
- novedosos
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Abstract
SE PROPORCIONA UN METODO PARA GENERAR METABOLITOS SINTETICOS DE CCI-779. SE DESCRIBEN CINCO DERIVADOS DE CCI-779 NOVEDOSOS, COMO ASI TAMBIEN METODOS PARA LA UTILIZACION DE ESTOS DERIVADOS PARA DETECTAR METABOLITOS DE CCI-779 EN MUESTRAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60033704P | 2004-08-10 | 2004-08-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8641501A1 true PA8641501A1 (es) | 2006-09-08 |
Family
ID=35159738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA20058641501A PA8641501A1 (es) | 2004-08-10 | 2005-08-09 | Derivados de cci-779 y metodo para su preparacion |
Country Status (15)
Country | Link |
---|---|
US (2) | US7332601B2 (es) |
EP (1) | EP1776370A1 (es) |
JP (1) | JP2008517874A (es) |
CN (1) | CN1993368A (es) |
AR (1) | AR050452A1 (es) |
AU (1) | AU2005292647A1 (es) |
BR (1) | BRPI0514206A (es) |
CA (1) | CA2577011A1 (es) |
GT (1) | GT200500216A (es) |
MX (1) | MX2007001676A (es) |
PA (1) | PA8641501A1 (es) |
PE (1) | PE20060642A1 (es) |
SV (1) | SV2006002188A (es) |
TW (1) | TW200616633A (es) |
WO (1) | WO2006038972A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100402031C (zh) | 2002-07-30 | 2008-07-16 | 惠氏公司 | 含有瑞帕霉素羟基酯的胃肠外制剂 |
WO2006038972A1 (en) * | 2004-08-10 | 2006-04-13 | Wyeth | Cci-779 derivatives and methods of making same |
EP1957500A1 (en) * | 2005-12-07 | 2008-08-20 | Wyeth a Corporation of the State of Delaware | Process for the preparation of purified crystalline cci-779 |
US7622578B2 (en) * | 2005-12-07 | 2009-11-24 | Wyeth | Scalable process for the preparation of a rapamycin 42-ester from a rapamycin 42-ester boronate |
AR058283A1 (es) * | 2005-12-07 | 2008-01-30 | Wyeth Corp | Metodos para la preparacion de rapamicina cristalina y para la medicion de la cristalinidad de los compuestos de rapamicina utilizando calorimetria diferencial de barrido |
TW200824713A (en) * | 2006-10-18 | 2008-06-16 | Wyeth Corp | Processes for the synthesis of individual isomers of mono-PEG CCI-779 |
TW200845960A (en) * | 2007-04-05 | 2008-12-01 | Wyeth Corp | Wortmannin-rapalog conjugate and uses thereof |
JP2014533294A (ja) | 2011-11-15 | 2014-12-11 | ノバルティス アーゲー | ホスホイノシチド3−キナーゼ阻害剤およびヤヌスキナーゼ2−シグナル伝達兼転写活性化因子5経路の調節剤の組合せ |
WO2014006115A1 (en) | 2012-07-06 | 2014-01-09 | Novartis Ag | Combination of a phosphoinositide 3-kinase inhibitor and an inhibitor of the il-8/cxcr interaction |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4316885A (en) | 1980-08-25 | 1982-02-23 | Ayerst, Mckenna And Harrison, Inc. | Acyl derivatives of rapamycin |
US5102876A (en) * | 1991-05-07 | 1992-04-07 | American Home Products Corporation | Reduction products of rapamycin |
US5256790A (en) * | 1992-08-13 | 1993-10-26 | American Home Products Corporation | 27-hydroxyrapamycin and derivatives thereof |
GB9307491D0 (en) * | 1993-04-08 | 1993-06-02 | Sandoz Ltd | Organic compounds |
WO1994025022A1 (en) * | 1993-04-23 | 1994-11-10 | Abbott Laboratories | Rapamycin conjugates and antibodies |
US7279561B1 (en) * | 1993-04-23 | 2007-10-09 | Wyeth | Anti-rapamycin monoclonal antibodies |
US5362718A (en) | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
US6277983B1 (en) | 2000-09-27 | 2001-08-21 | American Home Products Corporation | Regioselective synthesis of rapamycin derivatives |
TWI256395B (en) | 1999-09-29 | 2006-06-11 | Wyeth Corp | Regioselective synthesis of rapamycin derivatives |
WO2005016935A2 (en) | 2003-08-07 | 2005-02-24 | Wyeth | Regioselective synthesis of cci-779 |
AU2005238432A1 (en) | 2004-04-14 | 2005-11-10 | Wyeth | Process for preparing rapamycin 42-esters and FK-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies |
US7202256B2 (en) | 2004-04-14 | 2007-04-10 | Wyeth | Proline CCI-779, production of and uses therefor, and two-step enzymatic synthesis of proline CCI-779 and CCI-779 |
WO2005105811A1 (en) | 2004-04-14 | 2005-11-10 | Wyeth | Regiospecific synthesis of rapamycin 42-ester derivatives |
JP2007534337A (ja) | 2004-04-27 | 2007-11-29 | ワイス | ラパマイシン特異的メチラーゼを用いるラパマイシンの標識 |
WO2006038972A1 (en) * | 2004-08-10 | 2006-04-13 | Wyeth | Cci-779 derivatives and methods of making same |
US7538119B2 (en) | 2005-11-04 | 2009-05-26 | Wyeth | 41-Methoxy isotope labeled rapamycin 42-ester |
BRPI0708562A2 (pt) | 2006-03-07 | 2011-06-07 | Wyeth Corp | processos para preparar conjugados de polietileno glicor de macrolìdeos imunossupressores, um macrolìdeo imunossupressor peguilado, uma rapamicina peguilada, um everolimus peguilado, um cci-779 peguilado e um tacrolimus peguilado, e, produto |
-
2005
- 2005-08-09 WO PCT/US2005/028108 patent/WO2006038972A1/en active Application Filing
- 2005-08-09 JP JP2007525701A patent/JP2008517874A/ja not_active Withdrawn
- 2005-08-09 BR BRPI0514206-7A patent/BRPI0514206A/pt not_active IP Right Cessation
- 2005-08-09 SV SV2005002188A patent/SV2006002188A/es not_active Application Discontinuation
- 2005-08-09 CN CNA2005800266521A patent/CN1993368A/zh active Pending
- 2005-08-09 AR ARP050103319A patent/AR050452A1/es unknown
- 2005-08-09 US US11/200,383 patent/US7332601B2/en not_active Expired - Fee Related
- 2005-08-09 CA CA002577011A patent/CA2577011A1/en not_active Abandoned
- 2005-08-09 PA PA20058641501A patent/PA8641501A1/es unknown
- 2005-08-09 TW TW094126901A patent/TW200616633A/zh unknown
- 2005-08-09 AU AU2005292647A patent/AU2005292647A1/en not_active Abandoned
- 2005-08-09 MX MX2007001676A patent/MX2007001676A/es active IP Right Grant
- 2005-08-09 GT GT200500216A patent/GT200500216A/es unknown
- 2005-08-09 PE PE2005000922A patent/PE20060642A1/es not_active Application Discontinuation
- 2005-08-09 EP EP05824780A patent/EP1776370A1/en not_active Withdrawn
-
2007
- 2007-12-11 US US12/001,367 patent/US20100279364A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BRPI0514206A (pt) | 2008-06-03 |
AU2005292647A1 (en) | 2006-04-13 |
AR050452A1 (es) | 2006-10-25 |
MX2007001676A (es) | 2007-04-12 |
JP2008517874A (ja) | 2008-05-29 |
CN1993368A (zh) | 2007-07-04 |
CA2577011A1 (en) | 2006-04-13 |
US7332601B2 (en) | 2008-02-19 |
US20100279364A1 (en) | 2010-11-04 |
EP1776370A1 (en) | 2007-04-25 |
PE20060642A1 (es) | 2006-08-01 |
SV2006002188A (es) | 2006-03-15 |
GT200500216A (es) | 2006-03-02 |
US20060036091A1 (en) | 2006-02-16 |
TW200616633A (en) | 2006-06-01 |
WO2006038972A1 (en) | 2006-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8641501A1 (es) | Derivados de cci-779 y metodo para su preparacion | |
UY27748A1 (es) | Derivados de quinolina e isoquinolina, un método para su obtención y su uso como inhibidores de la inflamación. | |
CL2011002739A1 (es) | Compuestos derivados de 3-(1h-pirrolo[2,3-b]piridina-3-carbonil)-bencenosulfonamida; composicion farmaceutica que los comprende; kit; y su uso como inhibidores de raf para el tratamiento de una enfermedad o condicion seleccionada de melanoma, glioma, glioblastoma multiforme, cancer colorrectal, cancer de pulmon, entre otras. | |
ECSP077249A (es) | Nuevos hidratos y polimorfos de 4-[[(7r)-8-ciclopentil-7-etil-5,6,7,8-tetrahidro-5-metil-6-oxo-2-pteridinil]amino]-3-metoxi-n-(1-metil-4-piperidinil)-benzamida, procedimiento para su preparación y su uso como fármaco | |
UY29213A1 (es) | Derivados de quinolina e isoquinolina 5-sustitiuidos, un procedimiento para su preparación y su uso como inhibidores de la inflamación | |
EP2218792A4 (en) | PROCESS FOR PREPARATION OF A KOTPROBE, SOLUTION FOR PREPARATION OF A KOTPROBE AND KOTSAMMELKIT | |
IS8679A (is) | Skilvirk og valkvæm umbreyting koldíoxíðs í metanól, dímetýleter og afleidd myndefni þeirra | |
UA87487C2 (ru) | Полиморфные формы габоксадола, агониста gabaа, способ их получения и применение | |
NI200900081U (es) | Anticuerpos agonistas de trkb y sus usos. | |
BRPI0511396A (pt) | derivados de retinal e métodos para uso no tratamento de enfermidades visuais | |
DE502004009142D1 (de) | Verfahren zur herstellung substituierter 3-aryl-butyl-aminverbindungen | |
CR8765A (es) | Preparacion de pregabalina y compuestos relacionados | |
AR073954A2 (es) | Un metodo para controlar en forma dinamica un canal de comunicaciones inalambrico , un sistema de comunicaciones y un microprocesador | |
ATE541853T1 (de) | Tanaproget-derivate, metaboliten und verwendungen dafür | |
NO20066078L (no) | Metode for fremstilling av Entecavir og nye mellomprodukter derav via karbon-silisium oksidasjon | |
BRPI0514074A (pt) | aperfeiçoamentos em composições em bloco para lavatório | |
GT200500385A (es) | Aminoalcoholes triciclicos, procedimientos para su preparacion y su uso como inhibidores de inflamacion | |
ECSP077129A (es) | ||
BRPI0907298A2 (pt) | preparação solúvel em água, método para produzir uma preparação e uso de uma preparação | |
ATE458727T1 (de) | Zur modulation des 5-ht6-rezeptors, des 5-ht2a- rezeptors oder beider rezeptoren geeignete arylsulfonylbenzodioxane | |
UY29434A1 (es) | Derivados de tetrahidronaftalina, procedimientos para su preparación y su uso como inhibidores de la inflamacinn | |
EA200870148A1 (ru) | Производные сулиндака, их применение и получение | |
MX2007002277A (es) | Metodos para formar retinoides y usos de los mismos. | |
PA8644701A1 (es) | Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorios | |
CR7989A (es) | 7-alquinilamino- triazolopirimidinas, procedimientos para su obtencion y el uso de las mismas para controlar hongos nocivos, asi como productos que la contienen |